Team-Based Home Blood Pressure Monitoring
Launched by UNIVERSITY OF ROCHESTER · Aug 2, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach called Team-Based Home Blood Pressure Monitoring (TB-HBPM) to help people with high blood pressure better manage their condition. The goal is to find effective ways to have patients regularly send their home blood pressure readings to their healthcare team. By doing this, the team can provide support and guidance on how to improve blood pressure control, which is especially important because many patients, particularly from different racial backgrounds, struggle to manage their hypertension effectively.
To be part of this trial, you need to be between 18 and 85 years old and have a diagnosis of high blood pressure. You should also be a current patient at the healthcare practice participating in the study. If you join, you can expect to receive education on how to measure your blood pressure at home and learn about treatment options. The study will include team training for healthcare staff, as well as regular feedback to help improve patient care. This research aims to bridge gaps in care and ensure everyone has the support they need to manage their blood pressure successfully.
Gender
ALL
Eligibility criteria
- • ELIGIBILITY CRITERIA
- • Clinicians and Staff Eligibility Criteria Practice employees (practice leaders, administrators, clinicians, or staff) that work with hypertensive patients during the study period (scheduling appointments, coordinating care, measuring blood pressure, responding to questions, and/or treating their blood pressure)
- • Patient Inclusion Criteria
- • Current HFM patient 18-85 years of age with hypertension diagnosis
- • Diagnosis of hypertension based on ICD-10 codes of I10-I14
- • at least one HFM health visit and hypertension diagnosis beginning no later than 7/1/2021.
- • Patient Exclusion Criteria
- • Not current patient in the participating practices
- • Diagnosis of dementia, end-stage renal disease, and/or in hospice
- • Currently pregnant
About University Of Rochester
The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, New York, United States
Patients applied
Trial Officials
Kevin Fiscella, MD, MPH
Principal Investigator
URMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials